Lupin Diagnostics, a wholly-owned subsidiary of global pharma major Lupin, has chalked out plans to more than double its diagnostic laboratories and increase collection centres threefold across the country in five years.
Ravindra Kumar, CEO, Lupin Diagnostics, said: “At present, we have over 36 laboratories and 600 collection centres. Our goal is to have 100 laboratories by FY28 and 2,000 collections centres in five years.”
Kumar was in Chennai on Thursday to announce opening of regional reference laboratory in the city. Plans are to enter tier-II cities such as Coimbatore, Madurai, Tiruchi and Salem and agreements have been signed with the franchisees, he said.
He said that each region will have at least 25 laboratories. “Right now, we are present only in East, West and South. We will be entering North by FY27, Kerala and Gujarat soon, ” he said.
The number of collection centres will be ramped to 1,000 by FY25 and 2,000 in the next three years. He said that 10 out of 36 laboratories have already been accredited by NABL, 10 more are in the pipeline and five would get accreditation by FY24.
“Within two years of oeprations, 30% of our laboratories have attained NABL accreditation. We plan to scale up this to 45% by March 2024,” he said.
Lupin Diagnostics is looking at setting up franchise partners in Maharashtra, Assam, West Bengal, Bihar, Jharkhand, Chhatisgarh, Odisha, Telengana, Andhra Pradesh, Madhya Pradesh and Karnataka. Currently, the company has over 500 employees and over 1200 jobs are expected to be created in the next five years.